OLAYEMI O ONONOGBU
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BEDFORD, TX NPI 1003243379
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$1,253.33
- Category: General Payments
- Program years: PY2021–2023
- Record count: 72
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $241.36 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.36 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $105.48 | 1 |
| GlaxoSmithKline, LLC. | $36.61 | 2 |
| ABBVIE INC. | $31.58 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.33 | 1 |
| Teva Pharmaceuticals USA, Inc. | $23.69 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.67 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1004340079 | GlaxoSmithKline, LLC. | $18.26 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1004340239 | GlaxoSmithKline, LLC. | $18.35 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1009008263 | ABBVIE INC. | $15.65 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1009008271 | ABBVIE INC. | $15.93 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015477067 | Otsuka America Pharmaceutical, Inc. | $13.67 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056874133 | Teva Pharmaceuticals USA, Inc. | $23.69 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987953427 | Janssen Pharmaceuticals, Inc | $105.48 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996438573 | Boehringer Ingelheim Pharmaceuticals, Inc. | $30.33 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.